At its simplest, biotechnology is technology based on biology - biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the ...

In accordance with its Bylaws and Articles of Incorporation, the Biotechnology Innovation Organization (BIO) is governed by its Board of Directors. In general, candidates interested in joining the BIO ...

BIO Business Solutions offers StemBioSys access to world-class business partners at preferred prices. For a small company like ours, this combination is clearly a win-win proposition! Bob Hutchens, ...

Since Watson and Crick discovered DNA's double helix structure in 1953, the US has been a leader in biotechnology innovation. American excellence in this field has greatly benefited people around the ...

Download past BIO Industry Analysis reports, and sign up to be notified of upcoming reports.

As BIO 2026 comes to a close, we look ahead to biotech's sixth decade. Pioneering patients remind us why innovation matters, and experts outline what will shape biotech's next decade, and leaders warn ...

WASHINGTON D.C. – Today, the Biotechnology Innovation Organization (BIO), in partnership with Kearney, a global management consulting firm, released a first-of-its-kind report that assesses the ...

The contents of the member listings on the BIO Web site may not be reproduced or used in any form without prior written permission from BIO. For more information about members, please refer to the ...

The Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) released its latest biennial report on best practices in bioscience economic development ...

Principles for Ethical Engagement: BIO, Our Members, and Patient Advocacy Organizations ...

BIO is the world’s largest advocacy association representing biotechnology companies, academic and research institutions, state biotechnology centers and related organizations across the United States ...

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the resignation of FDA Commissioner Marty Makary. “Dr.